Evidence map›Paper›PMID 39568786›Full record

ArticleFrontiers in pediatrics2024

Challenges in institutional ethical review process and approval for international multicenter clinical studies in lower and middle-income countries: the case of PARITY study.

Eliana Lopez-Baron, Qalab Abbas, Paula Caporal, Asya Agulnik, Jonah E Attebery, Adrian Holloway, Niranjan Tex Kissoon, Celia Isabel Mulgado-Aguas, Kokou Amegan-Aho, Marianne Majdalani and 12 more

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Eliana Lopez-BaronDepartamento de Pediatría y Cuidado Crítico Pediátrico, Hospital Pablo Tobón Uribe, Universidad EIA, Medellín, Colombia.
Qalab AbbasDepartment of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan.
Paula CaporalHealth Systems Program, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Asya AgulnikDivision of Critical Care and Pulmonary Medicine, Department of Pediatrics, St Jude Children's Research Hospital, Memphis, TN, United States.
Jonah E AtteberyDepartment of Neurosurgery, Barrow Global, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.
Adrian HollowayDivision of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.
Niranjan Tex KissoonDepartment of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Celia Isabel Mulgado-AguasUnidad de Terapia Intensiva Pediátrica, Hospital General León, León, México.
Kokou Amegan-AhoDepartment of Pediatrics and Child Health, School of Medicine, University of Health and Allied Sciences, Ho, Ghana.
Marianne MajdalaniDivision of Pediatric Intensive Care Unit, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Carmen OcampoGrupo Quirón Salud, Clínica Imbanaco, Cali, Colombia.
Havugarurema PascalDepartment of Pediatrics and Child Health, University Teaching Hospital of Butare, Butare, Rwanda.
Erika MillerDivision of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.
Aimable KanyamuhungaDepartment of Pediatrics and Child Health, University Teaching Hospital of Kigali, Kigali, Rwanda.
Atnafu Mekonnen TekleabDepartment of Pediatrics and Child Health, St. Paul's Hospital Millennium Hospital Medical College, Addis Ababa, Ethiopia.
Tigist BachaDepartment of Pediatrics and Child Health, St. Paul's Hospital Millennium Hospital Medical College, Addis Ababa, Ethiopia.
Sebastian González-DambrauskasRed Colaborativa Pediátrica de Latinoamérica (LARed Network), Montevideo, Uruguay.
Adnan T BhuttaDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IA, United States.
Teresa B KortzDivision of Critical Care, Department of Pediatrics, University of California, San Francisco, CA, United States.
Srinivas MurthyDepartment of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC, Canada.
Kenneth E RemyDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, Cleveland, OH, United States.
Global Health Subgroup of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network

Funding

Fever Etiology and Prognostic Point-of-Care Biomarkers in African Children with Severe Febrile IllnessK23AI144029 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTZ, TERESA · 2020 to 2024
$984k
NIAID NIH HHS K23 AI144029
6 · The paper itself

Abstract

Background: One of the greatest challenges to conducting multicenter research studies in low and middle-income countries (LMICs) is the heterogeneity in regulatory processes across sites. Previous studies have reported variations in requirements with a lack of standardization in the Institutional Review Board (IRB) processes between centers, imposing barriers for approval, participation, and development of multicenter research. Objectives: To describe the regulatory process, variability and challenges faced by pediatric researchers in LMICs during the IRB process of an international multicenter observational point prevalence study (Global PARITY). Design: A 16-question multiple-choice online survey was sent to site principal investigators (PIs) at PARITY study participating centers to explore characteristics of the IRB process, costs, and barriers to research approval. A shorter survey was employed for sites that expressed interest in participating in Global PARITY and started the approval process, but ultimately did not participate in data collection (non-participating sites) to assess IRB characteristics. Results: Of the 91 sites that sought IRB approval, 46 were successful in obtaining approval and finishing the data collection process. The survey was completed by 46 (100%) participating centers and 21 (47%) non-participating centers. There was a significant difference between participating and non-participating sites in IRB approval of a waiver consent and in the requirement for a legal review of the protocol. The greatest challenge to research identified by non-participating sites was a lack of research time and the lack of institutional support. Conclusions: Global collaborative research is crucial to increase our understanding of pediatric critical care conditions in hospitals of all resource-levels and IRBs are required to ensure that this research complies with ethical standards. Critical barriers restrict research activities in some resource limiting countries. Increasing the efficiency and accessibility of local IRB review could greatly impact participation of resource limited sites and enrollment of vulnerable populations.

Indexed as

challengesethicsglobalInstitutional Review BoardsIRBslow- and middle-income countriesresearch

Identifiers

PMID39568786
PMCPMC11577162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.